Pseudoexfoliation Glaucoma Clinical Trials
2 recruiting trials for Pseudoexfoliation Glaucoma. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Pseudoexfoliation Glaucoma clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Okuvision GmbH (1), Wuerzburg University Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Transcorneal electrical stimulation (TES) with the OkuStim 2 System (device, 1 trial), followed by Trabeculopuncture.
Track Pseudoexfoliation Glaucoma trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma
Glaucoma is a progressive optic neuropathy with retinal ganglion cell loss which leads to visual field loss. Open-angle glaucoma is the most common form of glaucoma. The aim of...
Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy
The purpose of this study is to perform trabeculopuncture a test to determine the distal outflow tract function to predict the success of ab interno trabeculectomy.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Pseudoexfoliation Glaucoma, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pseudoexfoliation Glaucoma, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pseudoexfoliation Glaucoma, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.